Gilead Sciences Inc. (GILD)
|
|
|
| 52wk high: | |
| 52wk low: | |
| EPS: | |
| PE: | |
| Dividend: | |
| Yield: | |
| Market Cap: | |
| Exchange: |
Articles on Gilead Sciences Inc. (GILD)
125 articles
Filter by:
Latest Articles Most commented on articlesMost frequent authors on GILD
- SA Editor Miriam Metzinger(38)
- SA Editors(13)
- Centient Biotech Investor(10)
- SA Editor Eli Hoffmann(7)
- BioBlogger (6)
Most popular authors
(tracked in watchlists)
- Bespoke Investment Group(679)
- Trader Mark(633)
- SA Editor Eli Hoffmann(413)
- Andrew Wilkinson(407)
- Roger Nusbaum(405)
Most commented on authors
- SA Editor Miriam Metzinger(34)
- SA Editor Eli Hoffmann(31)
- R. Raynovich(20)
- Ohad Hammer(15)
- Market Folly(11)
- Hedge Fund Portfolio Tracking: Renaissance Technologies (Jim Simons), Q3 2008
- The 'Reflation' Top Ten Portfolio
- Fast Money Recap - Bullish on Biotech (1/5/09)
- Hedge Fund Tracking: Farallon Capital Management (Thomas Steyer), Q3 2008
- Long/Short Hedge Strategy for Smaller Cap Stocks
- S&P's Best and Worst of 2008
- Fast Money Recap - Trading the Times Square Ball (12/30/08)
- Too Much Optimism for Gilead Sciences?
- Is There a Legitimate Case for the Healthcare Providers ETF?
- Gilead Sciences: Smart Company, Great Track Record
- Five Things Worth Remembering About Healthcare in 2009
- Expecting Gilead Sciences to Move Higher
- Fast Money Recap - Has Ben Gone Nuts? (12/17/08)
- Hedge Fund Tracking: Bruce Kovner's Caxton Associates, Q3 2008
- Three Potential Biotech Takeover Targets
- More Focused Defensive Index
- Achillion Pharma: Hepatitis Drug Dev Pipeline Now Fully Funded
- Hedge Fund Tracking: Lee Ainslie's Maverick Capital, Q3 2008
- 5 Health Care Stocks for Value Investors
- Rigel Pharmaceuticals: Biotech Crisis or Opportunity?
- Recessionary Equity Strategies: Still Going for Growth
- Best Performing S&P 500 Stocks During the Bush Years
- Recessionary Equity Strategies: Flight to Quality
- Expanding the Defensive Growth Index Into Europe
- J.P. Morgan's 16 Picks in Troubled Times
- Gilead Turns in Sweet Earnings Numbers
- Wall Street Breakfast: Must-Know News
- Earnings on Tap for Thursday, Fingers Crossed
- Some Good News in Biotech
- 'When There's Blood in the Streets', Buy Biotech Stocks
- Hedge Fund Tracking: Caxton Associates (Bruce Kovner)
- Three Biotech ETFs: A Way To Follow the 'Smart Money' into Healthcare
- Board and Executive Compensation in S&P 500
- S&P 500's Best and Worst Net Income Change
- Time for Biotech? - Fast Money Recap (07/29/08)
- Biotech Bucks the Market Trend
- A Biotech Bloom in July
- Roche's Genentech Offer Sends Ripples Through Biotech
- Five Strategies to Survive the Markets
- Gilead Sciences: Industry Landscape, Strong Growth Make It a Buy
- Friday Options Update: MSFT, BAC, MIR, OSTK, GILD, BRL, MAT
Hedge Fund Jobs
Job Seekers: Search jobs by category, get job alerts by email or live feed, apply online See full list of jobs »
Employers: See all recruitment options, get applications online or by email Post a job »
3 new today)